MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a preclinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...

PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced that the Company requested a post-complete letter clarification ...

Amid ongoing speculation about Kamala Harris’s stepdaughter, Ella Emhoff, allegedly experiencing a mental breakdown following ...

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

"It is considered more painful than fibromyalgia or giving birth — even more painful than amputating a finger without anesthesia." View Entire Post › ...

Perry had been seeking treatment for depression and anxiety when he became addicted to intravenous ketamine, turning to ...

Kabir Nigam [Opens in a new window], Evidence indicates that ketamine is highly effective, has a lower side effect profile and is better tolerated compared to many augmentation strategies for ...

and then undergoing a talk therapy session. Doctors believe ketamine can treat her chronic pain — if she's approved by workers' comp It works in the brain by increasing what's called ...

She was in constant agony from the cramps ripping through her abdomen – a pain that could only be ... The number of adults undergoing treatment for ketamine-related issues has more than doubled ...

PharmaTher Holdings Ltd. (the "Company” or "PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has issued a ...

neurological and pain disorders. A recently published new peer-reviewed study on the real-world effectiveness of ketamine intravenous therapy demonstrated significant patient improvement for ...